On Friday, Shares of Electronics for Imaging, Inc. (NASDAQ:EFII), dropped -3.06% to $41.79.
Electronics for Imaging, declared its results for the first quarter of 2015.
For the quarter ended March 31, 2015, the Company stated record first quarter revenue of $194.6 million, up 3% contrast to first quarter 2014 revenue of $188.7 million. Non-GAAP operating income was $28.3 million contrast to $25.3 million for the same period in 2014. Non-GAAP net income was $21.4 million or $0.45 per diluted share, which comprised of an unfavorable non-operational currency impact of $0.02 per share, contrast to non-GAAP net income of $20.4 million or $0.42 per diluted share for the same period in 2014. GAAP operating income was $11.1 million contrast to $10.8 million for the same period in 2014. GAAP net income was $5.2 million or $0.11 per diluted share, contrast to $10.1 million or $0.21 per diluted share for the same period in 2014.
Electronics For Imaging, Inc. provides digital inkjet printers, business process automation solutions, and color digital front ends (DFE) in the United States and internationally. The company’s Industrial Inkjet segment offers VUTEk super-wide format UV, LED, textile dye sublimation, and thermoforming industrial digital inkjet printers and ink for use in commercial photo labs, sign shops, graphic screen printers, specialty commercial printers, and digital and billboard graphics providers.
Shares of Dyax Corp. (NASDAQ:DYAX), declined -3% to $27.44, during its last trading session.
Dyax, will host a webcast and conference call, counting an open question and answer session, Wednesday, April 29, 2015. During the call, administration will talk about the Company’s financial results for the first quarter 2015 as well as progress regarding its key value drivers – DX-2930, the KALBITOR® (ecallantide) business and the Licensing and Funded Research Portfolio (LFRP).
Dyax Corp., a biopharmaceutical company, identifies, develops, and commercializes treatments for hereditary angioedema (HAE) and other plasma-kallikrein-mediated (PKM) disorders. It offers KALBITOR for the treatment of acute attacks of HAE.
At the end of Friday’s trade, Shares of Flotek Industries Inc. (NYSE:FTK), dwindled -2.97% to $14.06, hitting its lowest level.
Flotek Industries, declared results for the three months ended March 31, 2015.
As stated on Form 10-Q filed with the U.S. Securities and Exchange Commission, Flotek stated that revenue for the three months ended March 31, 2015, was $82.4 million contrast to $102.6 million for the three months ended March 31, 2014. Merged revenue for the three months ended March 31, 2015, reduced $20.2 million, or 19.7%, relative to the comparable period of 2014. The decrease in revenue was driven by the steep decline in oilfield activity as indicated by the 25.5% decline in the average North American rig count.
For the three months ended March 31, 2015, the Company stated a net loss of $1.5 million, or $0.03 per common share (fully diluted), contrast to net income of $12.0 million, or $0.22 per common share (fully diluted) for the same period in 2014.
A portion of the loss – about $0.01 per share – is related to a settlement with the United States Environmental Protection Agency (“EPA”) concerning alleged violations of federal hazardous waste regulations at the Company’s FC Pro specialty chemical blending facility in Waller, Texas. Specifically, the EPA alleged that FC Pro failed to comply with certain notification, operating, and reporting requirements applicable to generators of hazardous waste. FC Pro has resolved the alleged violations following a consent agreement and final order under which it did not admit or deny the allegations and agreed to pay an administrative penalty of $410,868 in addition to certain other actions. The alleged violations involved procedural and registration issues and did not comprise any disposition or storage of hazardous materials. The alleged violations largely occurred before Flotek attained FC Pro, a division of Florida Chemical, in May, 2013. The amount of the civil penalty has been recorded as selling, general and administrative expense during the three months ended March 31, 2015.
Flotek Industries, Inc. develops and supplies oilfield products, services, and equipment to the oil, gas, and mining industries in the United States and internationally. Its Energy Chemical Technologies segment designs, develops, manufactures, packages, and markets specialty chemicals used in oil and gas well drilling, cementing, completion, stimulation, and production.
Finally, Goodrich Petroleum Corp. (NYSE:GDP), ended its last trade with -2.94% loss, and closed at $3.63.
Goodrich Petroleum’s administration team presented at IPAA’s 2015 Oil & Gas Investment Symposium at the Sheraton New York Times Square Hotel located at 811 7th Avenue in New York, New York on Monday, April 20, 2015.
Goodrich Petroleum Corporation, an independent oil and natural gas company, engages in the exploration, development, and production of oil and natural gas.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
